{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:22:35Z","timestamp":1777983755365,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017MYJ5TH"],"award-info":[{"award-number":["2017MYJ5TH"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["ID853981"],"award-info":[{"award-number":["ID853981"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-MAD-2022-12376110"],"award-info":[{"award-number":["PNRR-MAD-2022-12376110"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Airalzh Foundation","award":["AGYR2021 Life-Bio"],"award-info":[{"award-number":["AGYR2021 Life-Bio"]}]},{"name":"LIMPE-DISMOV Foundation Segala Grant 2021"},{"name":"DIGI-BRAIN the H2020 IMI IDEA-FAST","award":["ID853981"],"award-info":[{"award-number":["ID853981"]}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RF-2018-12366209"],"award-info":[{"award-number":["RF-2018-12366209"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 20202THZAW"],"award-info":[{"award-number":["PRIN 20202THZAW"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN202039WMFP"],"award-info":[{"award-number":["PRIN202039WMFP"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN COCOON (2017MYJ5TH)"],"award-info":[{"award-number":["PRIN COCOON (2017MYJ5TH)"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["022343"],"award-info":[{"award-number":["022343"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Recovery and Resilience Plan"},{"name":"MNESYS","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}]},{"name":"MNESYS","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}]},{"name":"Piano di Sostegno alla Ricerca, Universit\u00e0 degli Studi di Milano","award":["PSR2023_SPELU"],"award-info":[{"award-number":["PSR2023_SPELU"]}]},{"DOI":"10.13039\/100012357","name":"LifeArc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012357","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Karin Christiane Conradi Stiftungsfonds"},{"DOI":"10.13039\/501100010275","name":"Deutsche Gesellschaft f\u00fcr Muskelkranke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010275","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Frick-Foundation for ALS research"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CA 2915\/4-1"],"award-info":[{"award-number":["CA 2915\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondo Italiano per la Scienza","award":["FIS00000560"],"award-info":[{"award-number":["FIS00000560"]}]},{"DOI":"10.13039\/100006781","name":"Giovanni Armenise-Harvard Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018841","name":"Associazione Italiana Ricerca Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018841","id-type":"DOI","asserted-by":"publisher"}]},{"name":"H2020 IMI IDEA-FAST","award":["ID853981"],"award-info":[{"award-number":["ID853981"]}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["NRRP M6C2"],"award-info":[{"award-number":["NRRP M6C2"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39274-0","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:35:30Z","timestamp":1771234530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synaptic and cytoskeletal CSF signatures of motor neuron disease: the role of cyclase-associated protein 2"],"prefix":"10.1038","volume":"16","author":[{"given":"Andrea","family":"Pilotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pelucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Trasciatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Ferullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loris","family":"Poli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Tolassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Catanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Girotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Labella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Gorla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Stringhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Di Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"39274_CR1","doi-asserted-by":"publisher","first-page":"117727192095031","DOI":"10.1177\/1177271920950319","volume":"15","author":"E Camporesi","year":"2020","unstructured":"Camporesi, E. et al. Fluid biomarkers for synaptic dysfunction and loss. Biomark. Insights. 15, 1177271920950319 (2020).","journal-title":"Biomark. Insights"},{"key":"39274_CR2","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1186\/s12967-024-05767-7","volume":"22","author":"E. Agah","year":"2024","unstructured":"Agah, E. et al. CSF and blood levels of and Abeta-42 in amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Transl. Med. 22, 953 (2024).","journal-title":"J. Transl. Med."},{"key":"39274_CR3","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1212\/01.wnl.0000203129.82104.07","volume":"66","author":"GM Pasinetti","year":"2006","unstructured":"Pasinetti, G. M. et al. Identification of potential CSF biomarkers in ALS. Neurology 66, 1218\u20131222 (2006).","journal-title":"Neurology"},{"key":"39274_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fncel.2019.00256","volume":"13","author":"D Deshpande","year":"2019","unstructured":"Deshpande, D. et al. Synaptic FUS localization during motoneuron development and its accumulation in human ALS synapses. Front. Cell. Neurosci. 13, 256 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"39274_CR5","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1038\/s41467-021-23188-8","volume":"12","author":"S Sahadevan","year":"2021","unstructured":"Sahadevan, S. et al. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS. Nat. Commun. 12, 3027 (2021).","journal-title":"Nat. Commun."},{"key":"39274_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","volume":"185","author":"LR Fischer","year":"2004","unstructured":"Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 185, 232\u2013240 (2004).","journal-title":"Exp. Neurol."},{"key":"39274_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","volume":"74","author":"A Gaiani","year":"2017","unstructured":"Gaiani, A. et al. Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: Neurofilament light chain levels in definite subtypes of disease. JAMA Neurol. 74, 525\u2013532 (2017).","journal-title":"JAMA Neurol."},{"key":"39274_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/genes15040496","volume":"15","author":"P Shahim","year":"2024","unstructured":"Shahim, P. et al. Neurofilaments in sporadic and familial amyotrophic lateral sclerosis: A systematic review and meta-analysis. Genes (Basel). 15, 496 (2024).","journal-title":"Genes (Basel)"},{"key":"39274_CR9","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1093\/brain\/awv267","volume":"138","author":"E Portelius","year":"2015","unstructured":"Portelius, E. et al. Cerebrospinal fluid neurogranin: Relation to cognition and neurodegeneration in Alzheimer\u2019s disease. Brain 138, 3373\u20133385 (2015).","journal-title":"Brain"},{"key":"39274_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/jnnp-2021-327129","volume":"93","author":"S Halbgebauer","year":"2022","unstructured":"Halbgebauer, S. et al. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS. J. Neurol. Neurosurg. Psychiatry. 93, 68\u201374 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"39274_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/ana.70025","volume":"98","author":"C Steffke","year":"2025","unstructured":"Steffke, C. et al. Targeted proteomics upon treatment with tofersen identifies novel response markers for superoxide dismutase 1-linked amyotrophic lateral sclerosis. Ann. Neurol. 98(6), 1318\u20131334 https:\/\/doi.org\/10.1002\/ana.70025 (2025).","journal-title":"Ann. Neurol."},{"key":"39274_CR12","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/cells10061525","volume":"10","author":"F Schneider","year":"2021","unstructured":"Schneider, F., Metz, I., Khudayberdiev, S. & Rust, M. B. Functional redundancy of cyclase-associated proteins CAP1 and CAP2 in differentiating neurons. Cells 10, 1525 (2021).","journal-title":"Cells"},{"key":"39274_CR13","doi-asserted-by":"publisher","first-page":"151207","DOI":"10.1016\/j.ejcb.2022.151207","volume":"101","author":"MB Rust","year":"2022","unstructured":"Rust, M. B. & Marcello, E. Disease association of cyclase-associated protein (CAP): Lessons from gene-targeted mice and human genetic studies. Eur. J. Cell. Biol. 101, 151207 (2022).","journal-title":"Eur. J. Cell. Biol."},{"key":"39274_CR14","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1073\/pnas.1813351116","volume":"116","author":"L. J. Kepser","year":"2019","unstructured":"Kepser, L. J. et al. CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function. Proc. Natl. Acad. Sci. 116, 8397\u20138402 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39274_CR15","doi-asserted-by":"publisher","first-page":"fcaa086","DOI":"10.1093\/braincomms\/fcaa086","volume":"2","author":"S Pelucchi","year":"2020","unstructured":"Pelucchi, S. et al. Cyclase-associated protein 2 dimerization regulates cofilin in synaptic plasticity and Alzheimer\u2019s disease. Brain Commun. 2, fcaa086 (2020).","journal-title":"Brain Commun."},{"key":"39274_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ana.26045","volume":"89","author":"A Hannaford","year":"2021","unstructured":"Hannaford, A. et al. Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis. Ann. Neurol. 89, 979\u2013986 (2021).","journal-title":"Ann. Neurol."},{"key":"39274_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"39274_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum, J. M. et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J. Neurol. Sci. 169, 13\u201321 (1999).","journal-title":"J. Neurol. Sci."},{"key":"39274_CR19","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00415-020-09761-z","volume":"267","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh, S. et al. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis. J. Neurol. 267, 1699\u20131708 (2020).","journal-title":"J. Neurol."},{"key":"39274_CR20","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/alz.12554","volume":"18","author":"A Padovani","year":"2022","unstructured":"Padovani, A. et al. Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis. Alzheimer\u2019s Dement. 18, 2167\u20132175 (2022).","journal-title":"Alzheimer\u2019s Dement."},{"key":"39274_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/15622975.2017.1375556","volume":"19","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk, P. et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the consensus of the task force on biological markers in psychiatry of the world federation of societies of biological psychiatry. World J. Biol. Psychiatry. 19, 244\u2013328 (2018).","journal-title":"World J. Biol. Psychiatry"},{"key":"39274_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3233\/JAD-215646","volume":"87","author":"A Pilotto","year":"2022","unstructured":"Pilotto, A. et al. Differences between plasma and cerebrospinal fluid p-tau181 and p-tau231 in early Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 87, 991\u2013997 (2022).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"39274_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-024-00462-5","volume":"14","author":"A Padovani","year":"2025","unstructured":"Padovani, A. et al. Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer\u2019s disease and correlates with tau pathology. Transl. Neurodegener. 14, 1 (2025).","journal-title":"Transl. Neurodegener."},{"key":"39274_CR24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/cne.23266","volume":"521","author":"H Wootz","year":"2013","unstructured":"Wootz, H. et al. Alterations in the motor neuron\u2013renshaw cell circuit in the Sod1G93A mouse model. J. Comp. Neurol. 521, 1449\u20131469 (2013).","journal-title":"J. Comp. Neurol."},{"key":"39274_CR25","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1007\/s00018-007-7316-3","volume":"64","author":"V Peche","year":"2007","unstructured":"Peche, V. et al. CAP2, cyclase-associated protein 2, is a dual compartment protein. Cell. Mol. Life Sci. 64, 2702 (2007).","journal-title":"Cell. Mol. Life Sci."},{"key":"39274_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10488-7","volume":"7","author":"AM D\u2019Erchia","year":"2017","unstructured":"D\u2019Erchia, A. M. et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 7, 1\u201320 (2017).","journal-title":"Sci. Rep."},{"key":"39274_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s40478-023-01616-8","volume":"11","author":"O Aousji","year":"2023","unstructured":"Aousji, O. et al. Patterns of synaptic loss in human amyotrophic lateral sclerosis spinal cord: A clinicopathological study. Acta Neuropathol. Commun. 11, 120 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"39274_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00401-023-02611-y","volume":"146","author":"A Aly","year":"2023","unstructured":"Aly, A. et al. Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS. Acta Neuropathol. 146, 451\u2013475 (2023).","journal-title":"Acta Neuropathol."},{"key":"39274_CR29","doi-asserted-by":"publisher","first-page":"37968","DOI":"10.1038\/srep37968","volume":"6","author":"MJ Fogarty","year":"2016","unstructured":"Fogarty, M. J. et al. Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis. Sci. Rep. 6, 37968 (2016).","journal-title":"Sci. Rep."},{"key":"39274_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/ijms23031539","volume":"23","author":"A Di Maio","year":"2022","unstructured":"Di Maio, A. et al. Analysis of mRNA and protein levels of CAP2, DLG1 and ADAM10 genes in post-mortem brain of schizophrenia, Parkinson\u2019s and Alzheimer\u2019s disease patients. Int. J. Mol. Sci. 23, 1539 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"39274_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1750-3639.2010.00417.x","volume":"21","author":"CR Sunico","year":"2011","unstructured":"Sunico, C. R. et al. Reduction in the motoneuron inhibitory\/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis. Brain Pathol. 21, 1\u201315 (2011).","journal-title":"Brain Pathol."},{"key":"39274_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/cm.21282","volume":"73","author":"JR Bamburg","year":"2016","unstructured":"Bamburg, J. R. & Bernstein, B. W. Actin dynamics and cofilin-actin rods in Alzheimer disease. Cytoskeleton 73, 477\u2013497 (2016).","journal-title":"Cytoskeleton"},{"key":"39274_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainres.2012.02.059","volume":"1462","author":"M Polymenidou","year":"2012","unstructured":"Polymenidou, M. et al. Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res. 1462, 3\u201315 (2012).","journal-title":"Brain Res."},{"key":"39274_CR34","doi-asserted-by":"publisher","first-page":"e2065","DOI":"10.1212\/WNL.0000000000012853","volume":"97","author":"M Mila-Aloma","year":"2021","unstructured":"Mila-Aloma, M. et al. CSF synaptic biomarkers in the preclinical stage of Alzheimer disease and their association with MRI and PET: A cross-sectional study. Neurology 97, e2065\u2013e2078 (2021).","journal-title":"Neurology"},{"key":"39274_CR35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.brainresbull.2018.05.023","volume":"140","author":"MJ Fogarty","year":"2018","unstructured":"Fogarty, M. J. Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain Res. Bull. 140, 318\u2013333 (2018).","journal-title":"Brain Res. Bull."},{"key":"39274_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00401-020-02133-x","volume":"139","author":"M Nizzardo","year":"2020","unstructured":"Nizzardo, M. et al. Synaptotagmin 13 is neuroprotective across motor neuron diseases. Acta Neuropathol. 139, 837\u2013853 (2020).","journal-title":"Acta Neuropathol."},{"key":"39274_CR37","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41586-024-07042-7","volume":"626","author":"M Hruska-Plochan","year":"2024","unstructured":"Hruska-Plochan, M. et al. A model of human neural networks reveals NPTX2 pathology in ALS and FTLD. Nature 626, 1073\u20131083 (2024).","journal-title":"Nature"},{"key":"39274_CR38","doi-asserted-by":"publisher","first-page":"e14621","DOI":"10.1002\/alz.14621","volume":"21","author":"NJ Ashton","year":"2025","unstructured":"Ashton, N. J. et al. Biomarker discovery in Alzheimer\u2019s and neurodegenerative diseases using nucleic acid linked immuno-sandwich assay. Alzheimer\u2019s Dement. 21, e14621 (2025).","journal-title":"Alzheimer\u2019s Dement."},{"key":"39274_CR39","doi-asserted-by":"publisher","first-page":"e13918","DOI":"10.1111\/acel.13918","volume":"22","author":"S Pelucchi","year":"2023","unstructured":"Pelucchi, S. et al. An association study of cyclase-associated protein 2 and frailty. Aging Cell. 22, e13918 (2023).","journal-title":"Aging Cell."},{"key":"39274_CR40","doi-asserted-by":"publisher","first-page":"e083128","DOI":"10.1002\/alz.083128","volume":"19","author":"M Sauer","year":"2023","unstructured":"Sauer, M. et al. Blood-based SNAP\u201025 and VAMP\u20102 in Alzheimer\u2019s disease; Relation to cognition, atrophy and synaptic density. Alzheimer\u2019s Dement. 19, e083128 (2023).","journal-title":"Alzheimer\u2019s Dement."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39274-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39274-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39274-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:34:38Z","timestamp":1773221678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39274-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39274"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39274-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7933370\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Andrea Pilotto received consultancy\/speaker fees from Abbvie, Angelini, Bial, Eli Lilly, Lundbeck, Roche and Zambon pharmaceuticals. He acts as consultant as part of advisory Board of Angelini Pharma and BIAL pharmaceutics. Silvia Pelucchi declares no conflict of interest. Chiara Trasciatti declares no conflict of interest. Lucia Ferullo declares no conflict of interest. Loris Poli declares no conflict of interest. Chiara Tolassi declares no conflict of interest. Alberto Catanese declares no conflict of interest. Irene Girotto declares no conflict of interest. Beatrice Labella declares no conflict of interest. Federica Gorla declares no conflict of interest. Laura D\u2019Andrea declares no conflict of interest Ramona Stringhi declares no conflict of interest Monica di Luca received advisory board fees from Roche Elena Marcello received speaker fees from Eli Lilly and GE Healthcare, advisory board fees from Roche, teaching fees from Eisai Alessandro Padovani received personal compensation as a consultant\/scientific advisory board member for Biogen, Eisai Eli Lilly, General Healthcare (GE), Lundbeck, Nestl\u00e8, Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8703"}}